Amgen Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
167 result(s) found, displaying 71 to 80
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: romiplostim.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EVENITY romosozumab 105 mg/1.17mL injection solution syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANJINTI trastuzumab 150 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANJINTI trastuzumab 60 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANJINTI trastuzumab 420 mg powder for injection vial.